发明名称 IMIDAZOPYRIDINE COMPOUNDS AS 5-HT4 RECEPTOR MODULATORS
摘要 This invention provides a compound of the formula (I), or the pharmaceutically acceptable salts thereof wherein R<1> is hydrogen, halo or alkyl; R<2> and R<3> are independently hydrogen, alkyl, alkenyl, alkynyl, aminoalkyl or hydroxyalkyl; or R<2> and R<3> taken together with the nitrogen atom to which they are attached may form hetrocyclic; R<4> is hydrogen, halo, acyl, amino, amido, aryl, arylalkyl, or heteroaryl; R<5> is hydrogen, halo, alkyl, alkenyl, alkynyl, acyl, amino, amido, aryl, arylalkyl, or heteroaryl; R<6> is hydrogen, alkyl or alkoxyalkyl; X is NR<9> wherein R<9> is hydrogen or alkyl; and Y is (CR<7>R<8>) wherein n is an integer from 0 to 5. These compounds have 5-HT4 receptor binding activity, and thus are useful for the treatment of gastroesophageal reflux disease, non-ulcer dyspepsia, Functional dyspepsia, irritable bowel syndrome or the like in mammalian, especially humans. This invention also provides a pharmaceutical composition comprising the above compound.
申请公布号 WO03035649(A1) 申请公布日期 2003.05.01
申请号 WO2002IB04098 申请日期 2002.10.03
申请人 PFIZER PHARMACEUTICALS INC.;FENWICK, DAVID, ROY;GYMER, GEOFFREY, EDWARD;NOGUCHI, HIROHIDE;STOBIE, ALAN;UCHIDA, CHIKARA;PFIZER INC. 发明人 FENWICK, DAVID, ROY;GYMER, GEOFFREY, EDWARD;NOGUCHI, HIROHIDE;STOBIE, ALAN;UCHIDA, CHIKARA
分类号 A61K31/4545;A61P1/04;A61P1/08;A61P1/10;A61P1/14;A61P9/00;A61P9/04;A61P9/06;A61P9/10;A61P25/00;A61P25/04;A61P25/06;A61P25/22;A61P25/28;A61P43/00;C07D471/04;(IPC1-7):C07D471/04;A61K31/437 主分类号 A61K31/4545
代理机构 代理人
主权项
地址